Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C23H24N2O |
| Molecular Weight | 344.4495 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1CC[C@@]2(CC3=NC4=C(C=CC=C4)C=C3C[C@H]2C1)C5=CC=CC(O)=C5
InChI
InChIKey=LEPBHAAYNPPRRA-WMZHIEFXSA-N
InChI=1S/C23H24N2O/c1-25-10-9-23(18-6-4-7-20(26)13-18)14-22-17(12-19(23)15-25)11-16-5-2-3-8-21(16)24-22/h2-8,11,13,19,26H,9-10,12,14-15H2,1H3/t19-,23+/m0/s1
| Molecular Formula | C23H24N2O |
| Molecular Weight | 344.4495 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL236 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19362480 |
0.7 nM [EC50] |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 11:21:44 GMT 2025
by
admin
on
Wed Apr 02 11:21:44 GMT 2025
|
| Record UNII |
UY7TB22PB7
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
UY7TB22PB7
Created by
admin on Wed Apr 02 11:21:44 GMT 2025 , Edited by admin on Wed Apr 02 11:21:44 GMT 2025
|
PRIMARY | |||
|
DTXSID201018434
Created by
admin on Wed Apr 02 11:21:44 GMT 2025 , Edited by admin on Wed Apr 02 11:21:44 GMT 2025
|
PRIMARY | |||
|
148545-09-9
Created by
admin on Wed Apr 02 11:21:44 GMT 2025 , Edited by admin on Wed Apr 02 11:21:44 GMT 2025
|
PRIMARY | |||
|
TAN-67
Created by
admin on Wed Apr 02 11:21:44 GMT 2025 , Edited by admin on Wed Apr 02 11:21:44 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> AGONIST |
|